Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Gain the skills, dexterity and confidence to propel your career into senior management. Whether the goal is to create a standalone solution or fashion part of a complex talent development initiative, ...
Our CEPH-accredited public health programs prepare undergraduate, masters, and doctoral students using a curriculum focused on problem solving and real-life practical experiences. Learn more about ...
Early December of last year, we boarded a sleek longship in the Dutch capital of Amsterdam, its canals shimmering in the early evening light. Our voyage: a Christmas-market-themed river cruise through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback